Navigation Links
Monsanto Company Signs Share Subscription Agreement With Devgen
Date:9/14/2007

GHENT, Belgium and ST. LOUIS, Sept. 14 /PRNewswire-FirstCall/ -- Devgen (Eurolist: DEVG) and Monsanto Company (NYSE: MON) today announced that they have signed an agreement in which Monsanto has agreed, subject to certain customary conditions, to subscribe to 1,045,400 Devgen shares at 17.22 euro/share, totaling euro 18 million (25 million $) and representing 5.9% of the outstanding capital of Devgen NV. Closing is expected to take place no later than November 2007.

It is anticipated that Monsanto's becoming a shareholder of Devgen will complement the ongoing collaboration and technology exchange agreements of the companies.

"Devgen has served as a key collaborator with our technology organization for several years," said Robb Fraley, Ph.D., Chief Technology Officer at Monsanto. "We're excited to build upon our strong working relationship with Devgen. We believe this is an important part of supporting our collective mission of discovering and delivering new agricultural technologies to the farm."

"We welcome Monsanto as a shareholder," said Thierry Bogaert, Chief Executive Officer of Devgen. "This strengthens Devgen's ability to develop and commercialize innovative biotech traits and seeds that meet farmers' needs."

Pol Bamelis, Chairman of Devgen, added: "We are pleased to strengthen our relationship with Monsanto. I would like to take the opportunity to acknowledge the merits of my predecessor, Mr Pierre Hochuli, in forging this relationship and to thank him sincerely for his significant contribution to Devgen's progress during his 5-year tenure as chairman of Devgen."

About Devgen

Devgen is a top 10 public agro biotech company with agricultural business units focused on developing
'/>"/>

SOURCE Monsanto Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. Georgia stem cell company likely to stay put
3. Surgical products company wins Governors Business Plan Contest
4. Madison stem cell company gets $1M from state
5. Company still behind schedule on Milwaukee wireless project
6. Software company enters health space with RFID solutions on hold
7. Delaware company will keep NameProtect here
8. IPO-bound NimbleGen traveling in fast company
9. Wisconsin tries to woo another stem cell company
10. Company to operate in wireless Internet space
11. RedPrairie acquires Denver software company

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...IK, Iceland, November 24 ...nced that it has received notice from,the Nasdaq S...tock will be,suspended as of November 30, 2009 and...nd Exchange Commission, which will remove deCODE,s...ompany files an appeal to the Nasdaq,Listing Quali...
(Date:11/24/2009)... /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. ann...has allowed the patent application for,its nano-pa... NOD technology is a highly efficient approach to ... nano-particles to enable oral delivery of drugs,o...y is a platform technology,that can be applied to ...
(Date:11/24/2009)...cently approved the Promega PowerPlex 16 HS System...ating DNA records for the National DNA Index Syste...EB) -- The FBI recently approved the Promega Powe...articipating in, or generating DNA records for, th... contains more than seven million profiles and has...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
... Treatment Results in Improvements in Physical ...ife, SAN FRANCISCO, Oct. 27 More than half of pa...ctions of golimumab (CNTO 148),50 mg and 100 mg, a...mprovements in the joint and skin symptoms of acti...ults sustained through one year.,Golimumab-treated...
...ay, November 2, 2008 at this year,s liver meet...ember 4, SAN FRANCISCO, Oct. 27 Nonalcoholic ste...esity, and there is no approved,medical therapy fo...ers,tested the effects of weight reduction using a...To do so, 31 overweight or obese patients with NAS...
...ny Strengthens Board as Lead Products Approach ...ber 27 UK medical technology company,BioCeramic T...Richard Sykes,has accepted the role of Chairman of...an of pharmaceuticals company GlaxoSmithKline plc,...amic Therapeutics Ltd is a spinout from Imperial C...
Other Biology Technology:One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 2One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 3One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 4One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 5One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 6One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 7One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 8One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 9Intensive Lifestyle Intervention Program for Overweight or Obese Patients with Nonalcoholic Steatohepatitis Reduces Weight and Improves Overall Liver Health 2Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman 2
(Date:11/25/2009)... , On September 11, firefighters, police officers...ffort in the World Trade Center complex. They batt..., searched for survivors, tackled fires and evacua...contained an estimated 17,000 people. And making t...unications: frightened workers and their relatives...
(Date:11/25/2009)... , LA JOLLA, CAWhen you eat may be just as vita...s at the Salk Institute for Biological Studies. Th...xing and waning of thousands of genes in the liver...lled by food intake and not by the body,s circadia...eding time determines the activity of a large numb...
(Date:11/24/2009)... , Stents that keep weakened and flabby arteries ...ter six months, those stents are no longer needed ... unnecessary. Previously, doctors had no choice bu...an of Tel Aviv University,s Department of Biomedic...fiber platform that carries drugs where they,re ne...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2Noted Diagnostic Radiologists Joan Werber D O Ahmed Farag M D C M Join Forces to Create Diagnostic Imaging Specialists of Chicago 6490 1NuVasive To Present at the Piper Jaffray Health Care Conference and the J P Morgan SMid Cap Conference 6488 1NuVasive To Present at the Piper Jaffray Health Care Conference and the J P Morgan SMid Cap Conference 6488 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J P Morgan SMid Cap Conference 6488 3Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference 6486 1
...cations Currently in Use, Including Large Scale, ...hcare Solutions to be ...rnational,Inc. (OTC Bulletin Board: BKYI), a leade...eless public safety, announced today that the comp...t biometric applications at,the 2007 Biometric Tec...
...unch of SAFmodule(TM) 3.1 SP3 to expand Novell, M...thentication methods, AUSTIN, Texas, Sept. 20 SA... biometric authentication to Novell(R) eDirectory,...ramework with Novell,s,Novell Modular Authenticati...a component of eDirectory, Novell,s market-leading...
...ernational team of scientists has produced a new t...efficiently than other rice crops. Professor Andy ...VBI) has been working with colleagues in India, In... to identify, characterize and make use of a gene ...important grain crop. The research, which was rece...
Other Biology News:BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo 2BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo 3IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks 2HARDY rice: less water, more food 2HARDY rice: less water, more food 3
Rabbit Anti-Human GORASP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
FailSafe PCR 2X PreMix B from EPICENTRE Biotechnologies
Rat Whole Blood Non-Sterile Alsevers from Pel-Freez Biologicals
Anti-Endomorphin-2 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: